Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

CUSIP: 00461U105

Q2 2021 13F Holders as of 30 Jun 2021

Holder snapshot 7 signals
Share change
+10,561,143
Put/Call ratio
74%
SEC-reported price per share
$17.56
Number of holders
128
Value change
+$20,628,850
Number of buys
81
Open additional details 1 more signal available
Number of sells
49
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
138,752,791

Security key

00461U105

Report period

Q2 2021

Institutions

128

Top holders

10

Ownership snapshot

Top reported holders of ACRS - Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Venrock Adviser, LLC
Disclosed value leader
Venrock Adviser, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F Lead comparable stake: 2.7% Showing 1-6 of 15 holder rows.

Quick read

Venrock Adviser, LLC leads the comparable SEC ownership view at 2.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Venrock Adviser, LLC's linked filing trail.
Comparable ownership Top 5
Venrock Adviser, LLC 2.7%
Rock Springs Capital Management LP 2.6%
Foresite Capital Management IV, LLC 2.4%
ADAGE CAPITAL PARTNERS GP, L.L.C. 2.3%
RENAISSANCE TECHNOLOGIES LLC 2.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Venrock Adviser, LLC
13F
Company
13F
2.7%
$93,759,000
3,720,582 shares
31 Mar 2021
Rock Springs Capital Management LP
13F
Company
13F
2.6%
$89,944,000
3,569,192 shares
31 Mar 2021
Foresite Capital Management IV, LLC
13F
Company
13F
2.4%
$85,656,000
3,399,034 shares
31 Mar 2021
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
2.3%
$80,640,000
3,200,000 shares
31 Mar 2021
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
2.2%
$75,259,000
2,986,478 shares
31 Mar 2021
VANGUARD GROUP INC
13F
Company
13F
1.5%
$53,370,000
2,117,852 shares
31 Mar 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
128
Shares
56,004,936
Rows available
128
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders
95
Q2 2021 holders
128
Holder diff
33
Investor Q1 2021 Shares Q2 2021 Shares Share Diff Share Chg % Q1 2021 value Q2 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .